Search results for: fracture

Drugs Studied for Use in Rheumatoid Arthritis, Weight Loss

Michele B. Kaufman, PharmD, BCGP | August 1, 2014

Plus, rheumatology drug news from EULAR 2014

7 Tools to Identify Depression

Nancy Sharby, PT, DPT, MS | August 1, 2014

Why screening for depressive symptoms in patients with arthritis is needed

Orexin’s Yin/Yang Functions Regulate Bone Remodeling

Lara C. Pullen, PhD | July 3, 2014

Working both to support bone formation and suppress it, a new study reveals orexin neuropeptides are essential regulators of skeletal homeostasis

Lessons Learned from a Patient with Rheumatoid Arthritis

Sarah Troxell, RN, BSN | June 1, 2014

Sarah Troxell, RN, BSN, imparts what she’s learned about RA and medication management, assembling a team of health professionals and battling other health issues

New Osteoporosis Drugs Show Promise in Therapy Pipeline

Thomas R. Collins | June 1, 2014

Rheumatologists at the ACR’s State-of-the-Art Clinical Symposium in Chicago discuss medication alternatives to bisphosphonates that reduce bone resorption, build bone density and may provide new treatment options

Rheumatologist Marc C. Hochberg, MD, MPH, Advances Epidemiology Through Collaborative Ties

Gretchen Henkel | May 1, 2014

Accomplished physician noted for research in gout, osteoarthritis etiology; characterizing therapeutic responsiveness in disease states; inspiring teamwork among rheumatologists

U.S. Bone and Joint Initiative Summit Examines Quality of Patient-Centered Musculoskeletal Care

Kurt Ullman | May 1, 2014

Physicians discuss definition, implementation of best clinical practices for patient care at multidisciplinary meeting last November

Rheuminations: Ankylosing Spondylitis Sometimes Defies Detection

Simon M. Helfgott, MD | May 1, 2014

How method of diagnosing, treating this inflammatory back disease characterized by stiffness and the presence of HLA-B27 gene has evolved

Treating Early-Stage Spondyloarthritis May Prevent Disease Progression, Say Researchers at the ACR/ARHP Winter Rheumatology Symposium

Kimberly Retzlaff | April 2, 2014

Therapy with tumor necrosis factor inhibitors, nonsteroidal antiinflammatory drugs, ustekinumab in early stages of osteitis may halt molecular switching to bone-forming phenotype characteristic of SpA

Paleopathology Uses Patients from the Past to Investigate Today’s Diseases

Bruce Rothschild, MD | February 1, 2014

Evidence of disease in prehistoric skeletons can provide clues to early characteristics of rheumatoid arthritis, calcium pyrophosphate deposition disease, and other joint disorders